Precursor-directed biosynthesis of 6-deoxyerythronolide B analogues is improved by removal of the initial catalytic sites of the polyketide synthase |
| |
Authors: | Shannon L Ward Ruchir P Desai Zhihao Hu Hugo Gramajo Leonard Katz |
| |
Institution: | (1) Kosan Biosciences Inc., 3832 Bay Center Place, Hayward, CA 94545, USA;(2) Facultad de Ciencias Bioquimicas y Farmaceuticas, Universidad de Rosario, Suipacha 531, 2000 Rosario, Argentina |
| |
Abstract: | Precursor-directed biosynthesis has been shown to be a powerful tool for the production of polyketide analogues that would be difficult or cost prohibitive to produce from medicinal chemistry efforts alone. It has been most extensively demonstrated using a KS1 null mutation (KS10) to block the first round of condensation in the biosynthesis of the erythromycin polyketide synthase (DEBS) for the production of analogues of its aglycone, 6-deoxyerythronolide B (6-dEB). Here we show that removing the DEBS loading domain and first module (mod1Δ), rather than using the KS10 system, can lead to an increase in the utilization of some chemical precursors and production of 6-dEB analogues (R-6dEB) in both Streptomyces coelicolor and Saccharopolyspora erythraea. While the difference in utilization of the precursor was diketide specific, in strains fed (2R*, 3S*)-5-fluoro-3-hydroxy-2-methylpentanoate N-propionylcysteamine thioester, twofold increases in both utilization of the diketide and 15-fluoro-6dEB (15F-6dEB) production were observed in S. coelicolor, and S. erythraea exhibited a tenfold increase in production of 15-fluoro-erythromycin when utilizing the mod1Δ rather than the KS10 system. |
| |
Keywords: | Polyketide Erythromycin Genetic engineering |
本文献已被 PubMed SpringerLink 等数据库收录! |
|